Multiple Sclerosis Report

The Multiple sclerosis test is based on Whole Genome Sequencing Test. As such, it analyzes all Common and Rare Variants associated with Multiple sclerosis disease instead of a limited set of genes. Multiple sclerosis is a condition characterized by areas of damage (lesions) on the brain and spinal cord. These lesions are associated with destruction of the covering that protects nerves and promotes the efficient transmission of nerve impulses (the myelin sheath) and damage to nerve cells. The symptoms vary widely, and affected individuals can experience one or more effects of nervous system damage. Multiple sclerosis often causes sensory disturbances in the limbs, including a prickling or tingling sensation (paresthesia), numbness, pain, and itching. Along with environmental factors, Genetics plays a key role in the regulation of Multiple sclerosis. - 5 genes analyzed - 100% of genomic regions covered - Intragenic and intergenic regions analyzed - All variants reported."